“…Yet, the Delta Variant of Concern (VOC), formerly known as the Indian VOC or B 1.617.2, rapidly became the dominant strain of SARS-CoV-2 in most western countries, and its spread was found mainly in younger, more affluent groups [ 4 ]. The respiratory syndrome (fever, cough, respiratory difficulties) is the main feature and thus the main target for clinical screening of children with suspected COVID-19 [ 5 , 6 , 7 , 8 , 9 , 10 ]. Gastrointestinal (GI) symptoms related to COVID-19, such as vomiting, diarrhea, and abdominal pain, have emerged among extrapulmonary manifestations [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ].…”